Journals / Solunum / 2006 / Cilt: 8 - Sayı: 1

Enoksaparin ile antikoagülasyon sonrası rüptüre pulmoner enfarkta bağlı spontan hemotoraks: Olgu sunumu

Spontaneous hemothorax due to ruptured pulmonary infarction after anticoagulation with enoxaparin: A case report

Journal
Solunum
Pages
33–36
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The patient was successfully managed with discontinuation of anticoagulation, blood and plasma transfusions, chest tube drainage for evacuation of blood from the pleural space.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pulmonary thromboembolism remains a leading cause of morbidity and mortality.
📊
Key Findings & Data:Pulmonary infarction may occur only 10 % of pulmonary emboli but, the rupture of pulmonary infarction is a very rare condition in the chest diseases clinics.
💡
Conclusion & Impact:The patient was successfully managed with discontinuation of anticoagulation, blood and plasma transfusions, chest tube drainage for evacuation of blood from the pleural space.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Antikoagülanlar · Pulmoner emboli · Enoksaparin

Abstract

Pulmonary thromboembolism remains a leading cause of morbidity and mortality. Embolic obstruction of pulmonary vasculature may result in pulmonary hemorrhage but usually does not cause pulmonary infarction. Pulmonary infarction may occur only 10 % of pulmonary emboli but, the rupture of pulmonary infarction is a very rare condition in the chest diseases clinics. In the literature only a few case reports have been published. We report here spontaneous hemothorax that thought to be occurred due to ruptured pulmonary infarction in a case of pulmonary thromboembolism anticoagulated with enoxaparin (1mg/kg, bid, SC). The patient was successfully managed with discontinuation of anticoagulation, blood and plasma transfusions, chest tube drainage for evacuation of blood from the pleural space.

🔖

Cite This Article

BİRCAN, H. A., ŞAHİN, Ü., AKKAYA, A. (2006). Enoksaparin ile antikoagülasyon sonrası rüptüre pulmoner enfarkta bağlı spontan hemotoraks: Olgu sunumu. Solunum, Cilt: 8 - Sayı: 1, 33–36. https://ajindex.com/articles/314477

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Light RW. Pleural Diseases, 3rd ed, Baltimore,Williams and Wilkins, 1995
  2. Rostand RA, Feldman RL, Block ER. Massive hemothorax complicating heparin anticoagulation for pulmonary embolus. South Med J 1977;70:1128-1130
  3. Morecroft JA, Lea RE. Haemothorax- a complication of anticoagulation for suspected pulmonary embolism. Br J Clin Pract 1988;42:217-218
  4. Martinez FJ, Villanueva AG, Pickering R, et al. Spontaneous hemothorax. Report of 6 cases and review of the literature. Medicine 1992;71:354-368
  5. Palevsky HI,Kelley MA, Fishman AP. Pulmonary thromboembolic disease. In: Fishman AP, ed. Fishman’s Pulmonary Diseases and Disorders. 3rd ed. International Ed, McGraw Hill 1998; (Vol 2, Chapter 84) 1297-1329
  6. Robinson NMK,Thomas MR, Jewitt DE. Spontaneoushaemothorax as a complication of anti coagulation following coronary angioplasty. Respir Med 1995;89:629-630
  7. Mrug M, Mishra PV, Lusane HC, et al. Hemothorax and retroperitoneal hematoma after anticoagulation with enoxaparin. South Med J 2002;95:936-938
  8. WickMR, Ritter JH, Schuller D. Ruptured pulmonary infarction: a rare, fatal complication of thromboembolic disease. Mayo Clin Proc 2000;75:639-642
  9. Levine MN, Raskob G, Hirsh J. Hemorrhagic complications of long term anticoagulant therapy. Chest 1989; 95 (suppl): 26S-35S
  10. Levine MN,Raskob G,Landefeld S, etal.Hemorrhagic complications of anticoagulant treatment. Chest 2001;119 (suppl):108S-121S
  11. Noble S, Peters DH, Goa KL. Enoxaparin. A reapprasial of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disease. Drugs 1995;49:388-410
  12. Antman EM, McCabe CH, Gurfinkel EP, et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina non wavemyocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI)11B Trial. Circulation 1999; 100:1593-1601
  13. Gould MK, Dembitzer AD, Doyle RL, et al. Low-molecularweight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis.A meta analysis of randomized, controlled trials.Ann Intern Med 1999;130:800-809
  14. Dolovich LR, Ginsberg JS, Douketis JD, et al.Ameta-analysis comparing low molecular weight heparins with unfractionated heparin in the treatment of venous thromboembolism: Examining some unanswered questions regarding location of treatment, product type, and dosing frequency.Arch Intern Med 2000;160: 181-188.